Professor Penelope Meunier-Brock (Peppy), went to school in England but studied Medicine in French at Louvain and Paediatrics in Dutch at Leuven University in Belgium. She did a Fellowship at Great Ormond Street Hospital in London from 1986-88 when she became a founding member of the European Liver Tumour group (SIOPEL), and joined the European neuroblastoma group SIOPEN She did her PhD on cisplatin toxicity in infants and children. She returned to Leuven to set up the Paediatric Haematology/Oncology Unit there and became Professor of Paediatric Haematology and Oncology in 1994. In 1999 she was invited back to be Consultant Oncologist at GOSH where her focus became solid tumours, particularly hepatoblastoma and neuroblastoma. She actively participated in all SIOPEL trials and was appointed International Chair for SIOPEL 6. She was secretary of SIOPEN for 4 years, President from 2011-13 and currently remains on the Advisory Board. She retired from medical clinical practice in 2014, retrained and now works as a counsellor and continues to pursue the prevention of cisplatin ototoxicity through her consultancy with Fennec Pharmaceuticals.